Mechanisms of abnormal renal sodium handling in obesity hypertension

American Journal of Hypertension

Volumn 10, Issue 5 II SUPPL., 1997, Pages

  Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney; pressure natriuresis; renin angiotensin system; sodium excretion; sympathetic nervous system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; INSULIN; RENIN; SODIUM ION;

CONFERENCE PAPER; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NATRIURESIS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE;

EID: 0030923725     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)00075-7     Document Type: Conference Paper

References (49)

1. Alexander J, Dustan HP, Sims EAH, Tarazi R. Report of the Hypertension Task Force. U.S. Dept. of Health, Education, and Welfare publication 70-1631 (NIH). 9:1979;61-77 US Government Printing Office, Washington DC.
2. Najjar M, Rowland M, for the National Center for Health Statistics: Antropometric reference data and prevalence of overweight: United States, 1976-80. Washington, DC, Government Printing Office; 1987;11:238, 1-73. U.S. Dept. of Health and Human Services publication No. (PHS) 87-1688.
3. Najjar M, Rowland M, for the National Center for Health Statistics: Antropometric reference data and prevalence of overweight: United States, 1976-80. Washington, DC, Government Printing Office; 1987;11:238, 1-73. U.S. Dept. of Health and Human Services publication No. (PHS) 87-1688.
4. Kumanyika S. Obesity in black women. Epidemiol Rev. 9:1987;31-50.
5. Chiang BW, Perlman LV, Epstein FH. Overweight and hypertension: a review. Circulation. 39:1969;403-421.
6. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M. Weight and hypertension. Ann Intern Med. 98:1983;855-859.
7. Jones DW, Kim JS, Andrew ME, et al. Body mass index and blood pressures in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens. 12:1994;1433-1437.
8. Rocchini AP, Moorehead CP, DeRemer S, Bondie D. Pathogenesis of weight related changes in blood pressure in dogs. Hypertension. 12:1989;922-928.
9. Hall JE, Brands MW, Dixon WN, Smith MJ Jr: Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension 1993;12:922-299.
10. Reisen E, Abel R, Modan M, et al. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 198:1978;1-6.
11. Guyton AC. The surprising kidney-fluid mechanism for pressure control - its infinite gain! Hypertension. 16:1990;725-730.
12. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension. 15:1990;547-559.
13. Rocchini AP, Key J, Bordie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 321:1989;580-585.
14. Stepniakowski K, Nazzaro P, Egan BM. Hypertension in abdominally obese adults <45 years old is not salt sensitive. Hypertension (in press).
15. Granger JP, Nakamura J. Effect of chronic Na loading on arterial pressure and renal function in dogs with obesity-induced hypertension (abst). Hypertension. 19:((suppl I)):1992;1-135.
16. Reisin E, Messerli FH, Ventura HO, Frohlich ED. Renal hemodynamics in obese and lean essential hypertensive patients. Meserli FH. Kidney in Essential Hypertension. 1984;125-129 Martinus Nijhoff, Boston.
17. Hall JE, Zappe DH, Alonso-Galicia A, et al. Renal pathophysiology in obesity-induced hypertension. NIPS. 11:1996;255-261.
18. Reaven GM, Hoffman BB. A role for insulin in the aetiology and course of hypertension. Lancet. 2:1987;435-437.
19. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens. 2:1989;1255-1325.
20. Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension. 19:((suppl I)):1992;167-177.
21. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure. Hypertension. 7:1985;702-706.
22. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin resistant state. J Cardiovasc Pharmacol. 15:((suppl 5)):1990;S18-S25.
23. Young JB, Landsberg L. Diet-induced changes in sympathetic nervous system activity: possible implication for obesity and hypertension. J Chron Dis. 35:1982;879-886.
24. Anderson EA, Balon TW, Hoffman RP, et al. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 19:1992;621-627.
25. Hall JE. Hyperinsulinemia: a link between obesity and hypertension? Kidney Int. 43:1993;1402-1417.
26. Hall JE. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 23:1994;381-394.
27. Hall JE, Summers RL, Brands MW, et al. Resistance to metabolic actions of insulin and its role in hypertension. Am J Hypertens. 7:1994;772-788.
28. Rooney DP, Edgar JDM, Sheridan B, et al. The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal man. Eur J Clin Invest. 21:1991;430-435.
29. Brands MW, Hall JE. Insulin resistance, hyperinsulinemia and obesity-associated hypertension. J Am Soc Nephrol. 3:1992;1064-1077.
30. Hall JE, Brands MW, Zappe DH. Alonso-Galicia: Cardiovascular actions of insulin: are they important in long-term blood pressure regulation? Clin Exp Pharm Physiol. 22:1995;689-700.
31. Anderson EA, Mark AL. The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension. 21:1993;136-141.
32. Hall JE, Brands MW, Zappe DH, et al. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin resistant dogs. Hypertension. 25:1995;994-1002.
33. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol. 260:1991;R764-R768.
34. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive. Hypertension. 19:((suppl I)):1992;183-189.
35. Tuck ML, Sowers J, Dornfield L, et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med. 304:1981;930-933.
36. Robles RG, Villa E, Santirso R, et al. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am J Hypertens. 6:1993;1009-1019.
37. Hall JE, Van Vliet BN, Garrity CA, et al. Obesity hypertension - role of adrenergic mechanisms (abst). Hypertension. 21:1993;528.
38. Van Vliet BN, Hall JE, Mizelle HL, et al. Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol. 2:((pt 2)):1995;H629-H637.
39. Kassab S, Wilkins C, Kato T, et al. Renal nerves play an important role in mediating the sodium retention in response to a high fat diet in conscious dogs. Am J Hypertens. 7:1994;260.
40. Kassab S, Kato T, Wilkins FC, et al. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 25:((pt 2)):1995;893-897.
41. Zappe DH, Capel WT, Keen HL, et al. Role of renal afferent nerves in obesity-induced hypertension (abst). Am J Hypertens. 9:1996;20A.
42. Hildebrandt DA, Heath BJ, Hall JE. Systemic arterial pressure and heart rate responses to chronic carotid or vertebral artery insulin infusion (abst). FASEB J. 8:1994;A528.
43. Halaas JL, Gajiwala KS, Maffei M, et al. Weight reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
44. Chua SC Jr, Chung WK, Wu-Peng XS. Phenotypes of mouse diabetes and fatty rat due to mutation of the ob receptor. Science. 271:1996;994-996.
45. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:1996;292-295.
46. Jackson EK, Li P. Human leptin may function as a diuretic/natriuretic hormone (abst). Hypertension. 28:1996;51F.
47. Grekin RJ, Vollmer AP, Sider RS. Pressor effects of portal venous oleate infusion - a proposed mechanism for obesity hypertension. Hypertension. 26:1995;193-198.
48. Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner medulla of obese dogs. Hypertension. 25:((pt 2)):1995;888-892.
49. Arnold MD, Brissie R, Soonz JS, et al. Obesity associated renal medullary changes (abst). Lab Invest. 70:1994;156A.